FN London

Financial News

News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

BioNTech could produce vaccine for new virus variant within six weeks, CEO says

The press conference comes as the UK rolls out tougher restrictions and countries impose travel bans to contain the spread of the fast-spreading strain

By

Bérengère Sim

A vaccine for the new variant of Covid-19 could be manufactured within six weeks, according to BioNTech chief executive, Ugur Sahin
A vaccine for the new variant of Covid-19 could be manufactured within six weeks, according to BioNTech chief executive, Ugur Sahin Photo: Ian Forsyth/Getty Images

BioNTech could produce a vaccine for the new fast-spreading Covid-19 strain that has been found in the UK.

In a 22 December press conference, the chief executive of the German company Ugur Sahin said “the beauty of the messenger mRNA technology is we can directly start to engineer a vaccine that completely mimics this new mutation and we could manufacture a new vaccine within six weeks”.

WSJ Logo
GQG Launches Buyback After Stock Tumbles on Adani Probe

GQG Launches Buyback After Stock Tumbles on Adani Probe

Trump Considers Warsh Serving as Treasury Secretary—and Then Fed Chair

Large Accounting Firms Will Have to Submit Financial Statements to U.S. Regulator

Nvidia Is on Top but Does It Have Anywhere to Go but Down?

U.K. Consumers Cheerier Ahead of Holidays as Budget, U.S. Election Jitters Fade